I don't know about the questions you asked but the editor might be
interested in tying in their experience with the article in BMJ (week before
last) in which marketing of pharmaceuticals in the guise of 'education' is
discussed. Rachael Myr, in a rapid response to the journal questions whether
the formula manufacturers do the same (now would that be true??? :-)
That link might make their experience newsworthy.
http://www.bmj.com/cgi/content/full/322/7297/1312

Karleen Gribble
Australia


> Her editor was so interested in what R--- had done, especially after I
> suggested that her paper had been targeted for what was essentially free
> advertising, that she said she thought there might be a story right there
> too.  Which brings up my next question.  I havea copy of the fax that was
> sent to this reporter from the pharmaceutical company making all these
> claims.  What should we do with it?  Isn't there some sort of ethical
> violation here?  What if it is patently false?  What then?  Any ideas?

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html